Cargando…

Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway

Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. Convallatoxin, a natural cardiac glycoside, exhibits potent anti-tumor activities. Literature has confirmed that PTHR1 is highly expressed in OS tissues and cells and downregulation of PTHR1 could decrease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xin, Geng, Ze, Ding, Xiangyong, Lou, Yan, Zhang, Xingquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275893/ https://www.ncbi.nlm.nih.gov/pubmed/35635031 http://dx.doi.org/10.1080/21655979.2022.2080363

Ejemplares similares

Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma
por: Al-Khan, Awf A., et al.
Publicado: (2020)

Roles of Parathyroid Hormone-Related Protein (PTHrP) and Its Receptor (PTHR1) in Normal and Tumor Tissues: Focus on Their Roles in Osteosarcoma
por: Al-Khan, Awf A., et al.
Publicado: (2021)

Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways
por: Li, Shenglong, et al.
Publicado: (2017)

High endogenous expression of parathyroid hormone-related protein (PTHrP) supports osteogenic differentiation in human dental follicle cells
por: Pieles, Oliver, et al.
Publicado: (2020)

PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective
por: Sun, Chaonan, et al.
Publicado: (2021)

Tax1 binding protein 3 regulates osteogenic and adipogenic differentiation through inactivating Wnt/β‐catenin signalling
por: Wang, Yi, et al.
Publicado: (2023)

The genetic basis for inactivation of Wnt pathway in human osteosarcoma
por: Du, Xiaoling, et al.
Publicado: (2014)

Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells
por: Elango, Jeevithan, et al.
Publicado: (2019)

Aberrant WNT/β-catenin signaling in parathyroid carcinoma
por: Svedlund, Jessica, et al.
Publicado: (2010)

The Wnt/β-Catenin Pathway Interacts Differentially with PTHrP Signaling to Control Chondrocyte Hypertrophy and Final Maturation
por: Guo, Xizhi, et al.
Publicado: (2009)

Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway
por: Dai, Guo, et al.
Publicado: (2017)

ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway
por: Shan, Wulin, et al.
Publicado: (2022)

Convallatoxin, a Dual Inducer of Autophagy and Apoptosis, Inhibits Angiogenesis In Vitro and In Vivo
por: Yang, Seung Ya, et al.
Publicado: (2014)

Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo
por: Chang, Junli, et al.
Publicado: (2017)

Downregulation of the LncRNA MEG3 Promotes Osteogenic Differentiation of BMSCs and Bone Repairing by Activating Wnt/β-Catenin Signaling Pathway
por: Liu, Juan, et al.
Publicado: (2022)

Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level
por: Gurrado, Angela, et al.
Publicado: (2008)

PTHrP, its receptor, and protein kinase A activation in osteosarcoma
por: Walkley, Carl R, et al.
Publicado: (2014)

Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2020)

Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2022)

Effects of Glucocorticoids and Calcitonin on Parathyroid Hormone‐related Protein (PTHrP) Gene Expression and PTHrP Release in Human Cancer Cells Causing Humoral Hypercalcemia
por: Kasono, Keizo, et al.
Publicado: (1991)

SUN-720 LC-MS/MS Measurements of Parathyroid Hormone-Related Protein (PTHrP): Association Between Ca, PTH and PTHrP in Clinical Samples
por: Kushnir, Mark M, et al.
Publicado: (2020)

PTHrP Modulates the Proliferation and Osteogenic Differentiation of Craniofacial Fibrous Dysplasia-Derived BMSCs
por: Shen, Lihang, et al.
Publicado: (2023)

GSTZ1‐1 downregulates Wnt/β‐catenin signalling in hepatocellular carcinoma cells
por: Lei, Chong, et al.
Publicado: (2019)

Parathyroid Hormone-Related Peptide (PTHrP): Evaluation of Pediatric, Covariate-Stratified Reference Intervals
por: Brescia, Vincenzo, et al.
Publicado: (2022)

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance
por: Demaret, Tanguy, et al.
Publicado: (2022)

FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression
por: Guan, H, et al.
Publicado: (2015)

STARD3NL inhibits the osteogenic differentiation by inactivating the Wnt/β‐catenin pathway via binding to Annexin A2 in osteoporosis
por: Xu, Yuexin, et al.
Publicado: (2022)

LBSAT142 Discovery And Characterization Of A Potent And Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist For The Treatment Of Hypercalcemia
por: Rico-Bautista, Elizabeth, et al.
Publicado: (2022)

Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
por: Fang, Fang, et al.
Publicado: (2018)

TIMP-1 inhibits proliferation and osteogenic differentiation of hBMSCs through Wnt/β-catenin signaling
por: Liang, Tangzhao, et al.
Publicado: (2019)

Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice
por: Chao, Po-Kuan, et al.
Publicado: (2019)

The cardiac glycoside convallatoxin inhibits the growth of colorectal cancer cells in a p53-independent manner
por: Anderson, Sarah E., et al.
Publicado: (2017)

GABPB1-AS1 Promotes the Development of Osteosarcoma by Targeting SP1 and Activating the Wnt/β-Catenin Pathway
por: Chen, Jingyang, et al.
Publicado: (2022)

Interleukin-24 inhibits the phenotype and tumorigenicity of cancer stem cell in osteosarcoma via downregulation Notch and Wnt/β-catenin signaling
por: Zhuo, Baobiao, et al.
Publicado: (2021)

Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent Manner
por: Johnson, Rachelle W., et al.
Publicado: (2018)

Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus
por: Granno, Simone, et al.
Publicado: (2019)

The Role of Parathyroid Hormone-Related Protein (PTHrP) in Osteoblast Response to Microgravity: Mechanistic Implications for Osteoporosis Development
por: Camirand, Anne, et al.
Publicado: (2016)

Parathyroid Hormone Related Protein (PTHrP)-Associated Molecular Signatures in Tissue Differentiation and Non-Tumoral Diseases
por: Librizzi, Mariangela, et al.
Publicado: (2023)

Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers
por: Kaushik, Vivek, et al.
Publicado: (2017)

Convallatoxin, the primary cardiac glycoside in lily of the valley (Convallaria majalis), induces tissue factor expression in endothelial cells
por: Morimoto, Mami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sbmk4m7eba5bfnigc2dg3d5bhb